Ocular Therapeutix (OCUL) Other Non-Current Liabilities (2013 - 2026)

Ocular Therapeutix's Other Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $909000.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 93.44% year-over-year to $909000.0 in Q1 2026; TTM through Mar 2026 was $909000.0, a 93.44% decrease from a year earlier, with the FY2025 full-year figure at $13.9 million, up 9760.28% from the prior year.
• Other Non-Current Liabilities fell to $909000.0 in Q1 2026 per OCUL's latest filing, from $13.9 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $30.0 million in Q4 2023 and bottomed at $93000.0 in Q4 2022.
• The 5-year median for Other Non-Current Liabilities is $11.4 million (2023), against an average of $9.0 million.
• Across the five-year window, Other Non-Current Liabilities sank 99.54% in 2022 and surged 32144.09% in 2023, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $93000.0 in 2022, then jumped by 32144.09% to $30.0 million in 2023, then plunged by 99.53% to $141000.0 in 2024, then soared by 9760.28% to $13.9 million in 2025, then sank by 93.46% to $909000.0 in 2026.
• Per Business Quant, the three latest OCUL Other Non-Current Liabilities figures stand at $909000.0 (Q1 2026), $13.9 million (Q4 2025), and $15.0 million (Q3 2025).